Benazecare 5mg is indicated for the treatment of congestive heart failure in dogs and the treatment of chronic renal insufficiency (CRI) in cats. After being given orally benazepril is rapidly absorbed and converted into Benazeprilat, a highly specific and potent inhibitor of angiotensin converting enzyme (ACE). In dogs with heart failure, Benazeprilat lowers the blood pressure and volume loading effect on the heart. In cats with renal insufficiency, Benazeprilat reduces the protein loss in urine. Benazepril has been shown to increase the appetite, quality of life and the survival time of cats particularly in advanced disease.
In both dogs and cats, Benazecare 5 mg should be given orally once daily with or without food. The duration of treatment is unlimited.
Benazecare 5mg warnings: